Zobrazeno 1 - 5
of 5
pro vyhledávání: '"M. De Wilt"'
Publikováno v:
Journal of the Professional Association for Cactus Development. 18:25-39
The objective of this study was to replace gelatin in marshmallows with differentconcentrations of fluid mucilage, combined with different concentrations of powderedhydrocolloids. Nine different formulations were prepared: control (100% gelatin); 75%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2be4ec94e8f1b25af29047ac20fd7bf6
https://doi.org/10.56890/jpacd.v18i.51
https://doi.org/10.56890/jpacd.v18i.51
Autor:
de Steven Jong, Frank A.E. Kruyt, L. H. A. M. de Wilt, H. Groen, de Elisabeth G. E. Vries, J. H. Stegehuis
Publikováno v:
Drug Resistance Updates, 13, 2-15. Churchill Livingstone
Stegehuis, J H, de Wilt, L H A M, de Vries, E G, Groen, H J, de Jong, S & Kruyt, F A 2010, ' TRAIL receptor targeting therapies for non-small cell lung cancer: current status and perspectives ', Drug Resistance Updates, vol. 13, pp. 2-15 . https://doi.org/10.1016/j.drup.2009.11.001
Stegehuis, J H, de Wilt, L H A M, de Vries, E G, Groen, H J, de Jong, S & Kruyt, F A 2010, ' TRAIL receptor targeting therapies for non-small cell lung cancer: current status and perspectives ', Drug Resistance Updates, vol. 13, pp. 2-15 . https://doi.org/10.1016/j.drup.2009.11.001
Non-small cell lung cancer (NSCLC) is a common and often fatal malignancy, diagnosed at an advanced stage in more than half of the cases Chemo-resistance remains a major problem in the treatment of NSCLC patients with conventional chemotherapeutic ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::821c787251379a676a747d94d560e708
https://doi.org/10.1016/j.drup.2009.11.001
https://doi.org/10.1016/j.drup.2009.11.001
Publikováno v:
de Wilt, L H A M, Kroon, J, Jansen, G, de Jong, S, Peters, G J & Kruyt, F A E 2013, ' Bortezomib and TRAIL: A perfect match for apoptotic elimination of tumour cells? ', Critical Reviews in Oncology / Hematology, vol. 85, no. 3, pp. 363-372 . https://doi.org/10.1016/j.critrevonc.2012.08.001
Critical Reviews in Oncology / Hematology, 85(3), 363-372. Elsevier Ireland Ltd
Critical Reviews in Oncology / Hematology, 85(3), 363-372. Elsevier Ireland Ltd
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a cytokine that selectively eradicates tumour cells via specific cell surface receptors and is intensively explored for use as a novel anticancer approach. To enhance the efficacy of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0270a25aa82d0c362dbb14e20bb9e83
https://pubmed.ncbi.nlm.nih.gov/22944363
https://pubmed.ncbi.nlm.nih.gov/22944363
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.